Catalyst Wire Dossier Catalyst Wire Dossier

Anti-E1E2 (D32.10 Epitope-binding) antibodies

Anti-E1E2 D32.10 epitope-binding antibody
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-E1E2 (D32.10 Epitope-binding) antibodies, covering 2017-11-20 to 2017-11-20. Get the full timeline:

Most recent: Clinical Trial Update: Anti-E1E2 (D32.10 Epitope-binding) Antibodies Status Prior Therapy Favors Direct-acting Antiviral Treatment Efficacy

See pricing